Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00174837
Status:
COMPLETED
Last Update Posted:
2016-05-26
First Post:
2005-09-13
Brief Title:
TRACE Tirapazamine-Radiation And Cisplatin Evaluation
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Phase III Randomized Trial of Concomitant Radiation Cisplatin and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer
Status:
COMPLETED
Status Verified Date:
2016-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRACE
Brief Summary:
The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine cisplatin and radiation versus cisplatin and radiation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| SR259075 | None | None | None |